JPWO2022250050A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022250050A5
JPWO2022250050A5 JP2023523485A JP2023523485A JPWO2022250050A5 JP WO2022250050 A5 JPWO2022250050 A5 JP WO2022250050A5 JP 2023523485 A JP2023523485 A JP 2023523485A JP 2023523485 A JP2023523485 A JP 2023523485A JP WO2022250050 A5 JPWO2022250050 A5 JP WO2022250050A5
Authority
JP
Japan
Prior art keywords
nucleic acid
double
acid strand
stranded nucleic
acid complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023523485A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022250050A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/021251 external-priority patent/WO2022250050A1/ja
Publication of JPWO2022250050A1 publication Critical patent/JPWO2022250050A1/ja
Publication of JPWO2022250050A5 publication Critical patent/JPWO2022250050A5/ja
Pending legal-status Critical Current

Links

JP2023523485A 2021-05-25 2022-05-24 Pending JPWO2022250050A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021087941 2021-05-25
PCT/JP2022/021251 WO2022250050A1 (ja) 2021-05-25 2022-05-24 scpBNA又はAmNAを含むヘテロ核酸

Publications (2)

Publication Number Publication Date
JPWO2022250050A1 JPWO2022250050A1 (https=) 2022-12-01
JPWO2022250050A5 true JPWO2022250050A5 (https=) 2025-06-03

Family

ID=84228791

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023523485A Pending JPWO2022250050A1 (https=) 2021-05-25 2022-05-24

Country Status (5)

Country Link
US (1) US20240240183A1 (https=)
EP (1) EP4349986A4 (https=)
JP (1) JPWO2022250050A1 (https=)
CA (1) CA3221584A1 (https=)
WO (1) WO2022250050A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276019A (en) 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US5264423A (en) 1987-03-25 1993-11-23 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US5955599A (en) 1995-06-01 1999-09-21 Hybridon, Inc. Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages
WO2005073378A1 (en) * 2004-01-30 2005-08-11 Santaris Pharma A/S MODIFIED SHORT INTERFERING RNA (MODIFIED siRNA)
JP2009536222A (ja) 2006-05-05 2009-10-08 アイシス ファーマシューティカルズ, インコーポレーテッド Pcsk9の発現を調節するための化合物および方法
CA2666191C (en) 2006-10-09 2017-07-11 Santaris Pharma A/S Rna antagonist compounds for the modulation of pcsk9
ES2526295T5 (es) 2006-10-18 2021-05-04 Ionis Pharmaceuticals Inc Compuestos antisentido
JP6112569B2 (ja) * 2011-12-16 2017-04-12 国立大学法人 東京医科歯科大学 キメラ2重鎖核酸
EP3004347B1 (en) 2013-05-30 2018-09-26 National University Corporation Tokyo Medical and Dental University Double-stranded agents for delivering therapeutic oligonucleotides
CN106103463B (zh) * 2014-02-18 2018-11-30 国立大学法人大阪大学 桥连型核苷和核苷酸
WO2015168172A1 (en) 2014-04-28 2015-11-05 Isis Pharmaceuticals, Inc. Linkage modified oligomeric compounds
WO2016081600A1 (en) 2014-11-18 2016-05-26 Zata Pharmaceuticals, Inc. Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds
EP3517610A4 (en) * 2016-09-23 2020-05-27 National University Corporation Tokyo Medical and Dental University THROUGH HETERODUPLEX NUCLEIC ACID THROUGH BLOOD BRAIN CABINET
US11260134B2 (en) 2016-09-29 2022-03-01 National University Corporation Tokyo Medical And Dental University Double-stranded nucleic acid complex having overhang
KR20200014320A (ko) * 2017-05-31 2020-02-10 쿄와 기린 가부시키가이샤 Apcs의 발현을 억제하는 핵산
PE20211783A1 (es) * 2018-11-08 2021-09-08 Aligos Therapeutics Inc Polimeros oligonucleotidos que inhiben el transporte de antigenos y metodos
CN113677374A (zh) * 2019-04-08 2021-11-19 国立大学法人东京医科齿科大学 肌疾病治疗用药物组合物
EP4043565A4 (en) * 2019-10-11 2024-01-24 National University Corporation Tokyo Medical and Dental University MODIFIED HETERONUCLEIC ACID
JP7537896B2 (ja) 2019-11-21 2024-08-21 日本無機株式会社 エアフィルタ

Similar Documents

Publication Publication Date Title
US20230020192A1 (en) Compounds and methods for modulating c90rf72
CN113164509B (zh) 用于抑制17β-HSD 13型(HSD17B13)表达的RNAi试剂、其组合物和使用方法
DE60038495T2 (de) Oligonukleotid n3'-p5' thiophosphoramidate: ihre synthese und verwendung
JP2019214587A5 (https=)
JPWO2020209285A5 (https=)
JP2023134635A (ja) Lrrk2発現を低減するための化合物及び方法
IL289789B2 (en) Compounds and methods for lowering tau expression
JPWO2023022229A5 (https=)
JP2021533804A5 (https=)
CN110832077B (zh) 用于抑制α-ENaC表达的RNAi剂及使用方法
TWI803455B (zh) 單股寡核苷酸
JPH06502300A (ja) 遺伝子発現の抑制のための化合物及び方法
IL264216B1 (en) Compounds and methods for modulation of smn2
JP2019525918A5 (https=)
KR20240129626A (ko) 변형된 백본 화학을 갖는 스플라이스 스위처 안티센스 올리고뉴클레오티드
CN120505310A (zh) 用于调节smn2的化合物和方法
WO2024140101A1 (zh) 修饰的双链寡核苷酸分子、修饰的双链寡核苷酸缀合物及其用途
AU2017297624B2 (en) Compounds and methods for modulation of transcript processing
Koch et al. Locked nucleic acid
JPWO2021187392A5 (https=)
WO2019044974A1 (ja) スモールガイドアンチセンス核酸とその使用
JPWO2022250050A5 (https=)
WO2021157730A1 (ja) 核酸医薬とその使用
JP6934695B2 (ja) 核酸医薬とその使用
WO2024212954A1 (zh) 抑制lpa基因表达的化合物、药物组合物及其用途